| Product NDC: | 68258-3029 | 
| Proprietary Name: | Next Choice | 
| Non Proprietary Name: | levonorgestrel | 
| Active Ingredient(s): | .75 mg/1 & nbsp; levonorgestrel | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 68258-3029 | 
| Labeler Name: | Dispensing Solutions, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA078665 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20090904 | 
| Package NDC: | 68258-3029-1 | 
| Package Description: | 1 BLISTER PACK in 1 CARTON (68258-3029-1) > 2 TABLET in 1 BLISTER PACK | 
| NDC Code | 68258-3029-1 | 
| Proprietary Name | Next Choice | 
| Package Description | 1 BLISTER PACK in 1 CARTON (68258-3029-1) > 2 TABLET in 1 BLISTER PACK | 
| Product NDC | 68258-3029 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | levonorgestrel | 
| Dosage Form Name | TABLET | 
| Route Name | ORAL | 
| Start Marketing Date | 20090904 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Dispensing Solutions, Inc. | 
| Substance Name | LEVONORGESTREL | 
| Strength Number | .75 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Inhibit Ovum Fertilization [PE],Progesterone Congeners [Chemical/Ingredient],Progesterone Congeners [Chemical/Ingredient],Progestin [EPC],Progestin-containing Intrauterine Device [EPC] |